Cargando…
Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report
BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder occurring after a single dose of 3,4-methylenedioxymethamphetamine. Furthermore, we describe the use and efficacy of the Primary Care Behavioral Health model, a collaborative approach to integrative p...
Autores principales: | Kaplan, Kaeley, Kurtz, Fiona, Serafini, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968564/ https://www.ncbi.nlm.nih.gov/pubmed/29793521 http://dx.doi.org/10.1186/s13256-018-1670-7 |
Ejemplares similares
-
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013) -
Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report
por: Hui, Tianyi, et al.
Publicado: (2023) -
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015) -
Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011) -
Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)